Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies-Reference-Cited by-同舟云学术

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies

Published:2010-05 Issue:3 Volume:6 Page:133-140
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Burris Howard A.¹,Belani Chandra P.¹,Kaufman Peter A.¹,Gordon Alan N.¹,Schwartzberg Lee S.¹,Paroly Warren S.¹,Shahin Seta¹,Dreiling Lyndah¹,Saven Alan¹

Affiliation:

1. Sarah Cannon Research Institute, Nashville; West Clinic, Memphis, TN; Penn State Cancer Institute, Hershey, PA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH; M. D. Anderson Cancer Center at Orlando, Orlando, FL; North County Oncology Medical Clinic, Oceanside; Amgen, Thousand Oaks; and Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA

Abstract

Four tumor-specific studies were designed to assess the safety and efficacy of pegfilgrastim administered concurrently with chemotherapy.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.091094

Reference21 articles.

1. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

2. Delivering adjuvant chemotherapy to women with early-stage breast carcinoma

3. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

4. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer treatment with biosimilar drugs: A review;Cancer Innovation;2024-04

2. Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial;Medicine;2023-05-19

3. Two decades of pegfilgrastim: what have we learned? Where do we go from here?;Current Medical Research and Opinion;2023-04-08

4. Efficacy of same-day versus next-day administration of pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide: A retrospective multi-site analysis;Journal of Oncology Pharmacy Practice;2022-12-29

5. A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe;Supportive Care in Cancer;2022-08-31